Representative Jefferson Shreve (R-Indiana) recently bought shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). In a filing disclosed on March 09th, the Representative disclosed that they had ...

Opioid victims are not getting a "fair shake" in potential $7.4 billion settlement, a claimant in the Purdue Pharmacy ...

Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a bankruptcy case.

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

Shuttle Pharmaceuticals (SHPH) announced the pricing of an underwritten public offering of 19,166,667 shares of its common stock at a public ...

Recursion is currently generating limited revenue through partnerships with larger pharmaceutical leaders like Merck and ...

Goldman Sachs lowered the firm’s price target on Phathom Pharmaceuticals (PHAT) to $12 from $18 and keeps a Neutral rating on the shares after ...

and potentially re-rating the stock to $70/share. Collegium Pharmaceutical, Inc. (NASDAQ:COLL) is a specialty pharma company with a proven track record in commercializing drugs and growing them.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...